References
- 1Sullivan R, Yau WY, O’Connor E, Houlden H. Spinocerebellar ataxia: an update. J Neurol. 2019 Feb; 266(2): 533–544. DOI: 10.1007/s00415-018-9076-4
- 2Coarelli G, Coutelier M, Durr A. Autosomal dominant cerebellar ataxias: new genes and progress towards treatments. Lancet Neurol. 2023 Aug; 22(8): 735–749. DOI: 10.1016/S1474-4422(23)00068-6.
- 3Klockgether T, Mariotti C, Paulson HL. Spinocerebellar ataxia. Nat Rev Dis Primers. 2019 Apr 11; 5(1): 24. DOI: 10.1038/s41572-019-0074-3
- 4Magrinelli F, Latorre A, Balint B, et al. Isolated and combined genetic tremor syndromes: a critical appraisal based on the 2018 MDS criteria. Parkinsonism Relat Disord. 2020 Aug; 77: 121–140. DOI: 10.1016/j.parkreldis.2020.04.010
- 5Harding AE. The clinical features and classification of the late onset autosomal dominant cerebellar ataxias. A study of 11 families, including descendants of the ‘the Drew family of Walworth’. Brain. 1982 Mar; 105(Pt 1): 1–28. DOI: 10.1093/brain/105.1.1
- 6Lai RY, Tomishon D, Figueroa KP, et al. Tremor in the Degenerative Cerebellum: Towards the Understanding of Brain Circuitry for Tremor. Cerebellum. 2019 Jun; 18(3): 519–526. DOI: 10.1007/s12311-019-01016-6
- 7Lee WY, Jin DK, Oh MR, et al. Frequency analysis and clinical characterization of spinocerebellar ataxia types 1, 2, 3, 6, and 7 in Korean patients. Arch Neurol. 2003 Jun; 60(6): 858–63. DOI: 10.1001/archneur.60.6.858
- 8Rüb U, Bürk K, Timmann D, et al. Spinocerebellar ataxia type 1 (SCA1): new pathoanatomical and clinico-pathological insights. Neuropathol Appl Neurobiol. 2012 Dec; 38(7): 665–80. DOI: 10.1111/j.1365-2990.2012.01259.x
- 9Schmitz-Hübsch T, Coudert M, Bauer P, et al. Spinocerebellar ataxia types 1, 2, 3, and 6: disease severity and nonataxia symptoms. Neurology. 2008 Sep 23; 71(13): 982–9. DOI: 10.1212/01.wnl.0000325057.33666.72
- 10Genis D, Matilla T, Volpini V, et al. Clinical, neuropathologic, and genetic studies of a large spinocerebellar ataxia type 1 (SCA1) kindred: (CAG)n expansion and early premonitory signs and symptoms. Neurology. 1995 Jan; 45(1): 24–30. DOI: 10.1212/wnl.45.1.24
- 11Gan SR, Wang J, Figueroa KP, et al. Postural Tremor and Ataxia Progression in Spinocerebellar Ataxias. Tremor Other Hyperkinet Mov (N Y). 2017 Oct 9; 7: 492. DOI: 10.5334/tohm.346
- 12Sonakar AK, Shamim U, Srivastava MP, Faruq M, Srivastava AK. SCA2 in the Indian population: Unified haplotype and variable phenotypic patterns in a large case series. Parkinsonism Relat Disord. 2021 Aug; 89: 139–145. DOI: 10.1016/j.parkreldis.2021.07.011
- 13Schöls L, Peters S, Szymanski S, et al. Extrapyramidal motor signs in degenerative ataxias. Arch Neurol. 2000 Oct; 57(10): 1495–500. DOI: 10.1001/archneur.57.10.1495
- 14Balakrishnan S, Aggarwal S, Muthulakshmi M, et al. Clinical and Molecular Spectrum of Degenerative Cerebellar Ataxia: A Single Centre Study. Neurol India. 2022 May–Jun; 70(3): 934–942. DOI: 10.4103/0028-3886.349660
- 15Mizushima K, Watanabe M, Abe K, et al. Analysis of spinocerebellar ataxia type 2 in Gunma Prefecture in Japan: CAG trinucleotide expansion and clinical characteristics. J Neurol Sci. 1998 Apr 1; 156(2): 180–5. DOI: 10.1016/s0022-510x(98)00040-9
- 16Filla A, De Michele G, Santoro L, et al. Spinocerebellar ataxia type 2 in southern Italy: a clinical and molecular study of 30 families. J Neurol. 1999 Jun; 246(6): 467–71. DOI: 10.1007/s004150050385
- 17Stezin A, Venkatesh SD, Thennarasu K, et al. Non-ataxic manifestations of Spinocerebellar ataxia-2, their determinants and predictors. J Neurol Sci. 2018 Nov 15; 394: 14–18. DOI: 10.1016/j.jns.2018.08.024
- 18Jhunjhunwala K, Netravathi M, Purushottam M, Jain S, Pal PK. Profile of extrapyramidal manifestations in 85 patients with spinocerebellar ataxia type 1, 2 and 3. J Clin Neurosci. 2014 Jun; 21(6): 1002–6. DOI: 10.1016/j.jocn.2013.10.021
- 19Radhakrishnan DM, Goyal V, Srivastava AK, Shukla G, Behari M. Evaluation of Various Movement Disorders in Patients of Genetically Proven Spinocerebellar Ataxia: A Study from a Tertiary Care Center in Northern India. Ann Indian Acad Neurol. 2018 Jan–Mar; 21(1): 24–28. DOI: 10.4103/aian.AIAN_266_17
- 20Moro A, Munhoz RP, Moscovich M, Arruda WO, Raskin S, Teive HA. Movement disorders in spinocerebellar ataxias in a cohort of Brazilian patients. Eur Neurol. 2014; 72(5–6): 360–2. DOI: 10.1159/000365285
- 21Schöls L, Gispert S, Vorgerd M, et al. Spinocerebellar ataxia type 2. Genotype and phenotype in German kindreds. Arch Neurol. 1997 Sep; 54(9): 1073–80. DOI: 10.1001/archneur.1997.00550210011007
- 22Cancel G, Dürr A, Didierjean O, et al. Molecular and clinical correlations in spinocerebellar ataxia 2: a study of 32 families. Hum Mol Genet. 1997 May; 6(5): 709–15. DOI: 10.1093/hmg/6.5.709
- 23Garcia Ruiz PJ, Mayo D, Hernandez J, Cantarero S, Ayuso C. Movement disorders in hereditary ataxias. J Neurol Sci. 2002 Oct 15; 202(1–2): 59–64. DOI: 10.1016/s0022-510x(02)00211-3
- 24Geschwind DH, Perlman S, Figueroa CP, Treiman LJ, Pulst SM. The prevalence and wide clinical spectrum of the spinocerebellar ataxia type 2 trinucleotide repeat in patients with autosomal dominant cerebellar ataxia. Am J Hum Genet. 1997 Apr; 60(4): 842–50
- 25Sun H, Satake W, Zhang C, et al. Genetic and clinical analysis in a Chinese parkinsonism-predominant spinocerebellar ataxia type 2 family. J Hum Genet. 2011 Apr; 56(4): 330–4. DOI: 10.1038/jhg.2011.14
- 26Pirker W, Back C, Gerschlager W, Laccone F, Alesch F. Chronic thalamic stimulation in a patient with spinocerebellar ataxia type 2. Mov Disord. 2003 Feb; 18(2): 222–5. DOI: 10.1002/mds.10192
- 27Isobe T, Sato H, Goto T, Yako T, Yoshida K, Hashimoto T. Long-Term Suppression of Disabling Tremor by Thalamic Stimulation in a Patient with Spinocerebellar Ataxia Type 2. Stereotact Funct Neurosurg. 2019; 97(4): 241–243. DOI: 10.1159/000504062
- 28Velázquez-Pérez L, Medrano-Montero J, Rodríguez-Labrada R, et al. Cuban Hereditary Ataxias Network. Hereditary Ataxias in Cuba: A Nationwide Epidemiological and Clinical Study in 1001 Patients. Cerebellum. 2020 Apr; 19(2): 252–264. DOI: 10.1007/s12311-020-01107-9
- 29Sasaki H, Wakisaka A, Sanpei K, et al. Phenotype variation correlates with CAG repeat length in SCA2–a study of 28 Japanese patients. J Neurol Sci. 1998 Aug 14; 159(2): 202–8. DOI: 10.1016/s0022-510x(98)00166-x
- 30Sarva H, Severt WL, Jacoby N, Pullman SL, Saunders-Pullman R. Secondary orthostatic tremor in the setting of cerebellar degeneration. J Clin Neurosci. 2016 May; 27: 173–5. DOI: 10.1016/j.jocn.2015.10.027
- 31Bonnet C, Apartis E, Anheim M, et al. Tremor-spectrum in spinocerebellar ataxia type 3. J Neurol. 2012 Nov; 259(11): 2460–70. DOI: 10.1007/s00415-012-6531-5
- 32Gan SR, Figueroa KP, Xu HL, et al. The impact of ethnicity on the clinical presentations of spinocerebellar ataxia type 3. Parkinsonism Relat Disord. 2020 Mar; 72: 37–43. DOI: 10.1016/j.parkreldis.2020.02.004
- 33Lu CS, Chang HC, Kuo PC, et al. The parkinsonian phenotype of spinocerebellar ataxia type 3 in a Taiwanese family. Parkinsonism Relat Disord. 2004 Aug; 10(6): 369–73. DOI: 10.1016/j.parkreldis.2004.03.009
- 34Ishida C, Sakajiri K, Yoshikawa H, et al. Lower limb tremor in Machado-Joseph disease. Neurology. 1998 Oct; 51(4): 1225–6. DOI: 10.1212/wnl.51.4.1225
- 35Shirai S, Yabe I, Naganuma R, et al. Tremor during orthostatism as the initial symptom of Machado-Joseph disease. Clin Neurol Neurosurg. 2018 Oct; 173: 173–175. DOI: 10.1016/j.clineuro.2018.08.009
- 36Miura M, Numasawa Y, Takahisa M, et al. Levodopa-responsive truncal tremor in a patient with spinocerebellar ataxia type 3. J Neurol Sci. 2018 Sep 15; 392: 32–33. DOI: 10.1016/j.jns.2018.06.023
- 37Juvonen V, Hietala M, Päivärinta M, et al. Clinical and genetic findings in Finnish ataxia patients with the spinocerebellar ataxia 8 repeat expansion. Ann Neurol. 2000 Sep; 48(3): 354–61. DOI: 10.1002/1531-8249(200009)48:3<;354::AID-ANA10>3.0.CO;2-A
- 38Wu YR, Lin HY, Chen CM, et al. Genetic testing in spinocerebellar ataxia in Taiwan: expansions of trinucleotide repeats in SCA8 and SCA17 are associated with typical Parkinson’s disease. Clin Genet. 2004 Mar; 65(3): 209–14. DOI: 10.1111/j.0009-9163.2004.00213.x
- 39Samukawa M, Hirano M, Saigoh K, et al. PSP-Phenotype in SCA8: Case Report and Systemic Review. Cerebellum. 2019 Feb; 18(1): 76–84. DOI: 10.1007/s12311-018-0955-0
- 40Baba Y, Uitti RJ, Farrer MJ, Wszolek ZK. Sporadic SCA8 mutation resembling corticobasal degeneration. Parkinsonism Relat Disord. 2005 May; 11(3): 147–50. DOI: 10.1016/j.parkreldis.2004.10.008
- 41Smetcoren C, Weckhuysen D. SCA 8 mimicking MSA-C. Acta Neurol Belg. 2016 Jun; 116(2): 221–2. DOI: 10.1007/s13760-015-0523-z
- 42Zhou Y, Yuan Y, Liu Z, et al. Genetic and clinical analyses of spinocerebellar ataxia type 8 in mainland China. J Neurol. 2019 Dec; 266(12): 2979–2986. DOI: 10.1007/s00415-019-09519-2
- 43Gupta A, Jankovic J. Spinocerebellar ataxia 8: variable phenotype and unique pathogenesis. Parkinsonism Relat Disord. 2009 Nov; 15(9): 621–6. DOI: 10.1016/j.parkreldis.2009.06.001
- 44Kumar N, Miller GM. White matter hyperintense lesions in genetically proven spinocerebellar ataxia 8. Clin Neurol Neurosurg. 2008 Jan; 110(1): 65–8. DOI: 10.1016/j.clineuro.2007.08.014
- 45Domingues BMD, Nascimento FA, Meira AT, et al. Clinical and Genetic Evaluation of Spinocerebellar Ataxia Type 10 in 16 Brazilian Families. Cerebellum. 2019 Oct; 18(5): 849–854. DOI: 10.1007/s12311-019-01064-y
- 46Bahl S, Virdi K, Mittal U, et al. Evidence of a common founder for SCA12 in the Indian population. Ann Hum Genet. 2005 Sep; 69(Pt 5): 528–34. DOI: 10.1046/j.1529-8817.2005.00173.x
- 47Srivastava AK, Choudhry S, Gopinath MS, et al. Molecular and clinical correlation in five Indian families with spinocerebellar ataxia 12. Ann Neurol. 2001 Dec; 50(6): 796–800. DOI: 10.1002/ana.10048
- 48Srivastava AK, Takkar A, Garg A, Faruq M. Clinical behaviour of spinocerebellar ataxia type 12 and intermediate length abnormal CAG repeats in PPP2R2B. Brain. 2017 Jan; 140(1): 27–36. DOI: 10.1093/brain/aww269
- 49Holmes SE, O’Hearn EE, McInnis MG, et al. Expansion of a novel CAG trinucleotide repeat in the 5’ region of PPP2R2B is associated with SCA12. Nat Genet. 1999 Dec; 23(4): 391–2. DOI: 10.1038/70493
- 50Holmes SE, Hearn EO, Ross CA, Margolis RL. SCA12: an unusual mutation leads to an unusual spinocerebellar ataxia. Brain Res Bull. 2001 Oct–Nov 1; 56(3–4): 397–403. DOI: 10.1016/s0361-9230(01)00596-2
- 51Ganaraja VH, Holla VV, Stezin A, et al. Clinical, Radiological, and Genetic Profile of Spinocerebellar Ataxia 12: A Hospital-Based Cohort Analysis. Tremor Other Hyperkinet Mov (N Y). 2022 Apr 21; 12: 13. DOI: 10.5334/tohm.686
- 52Brussino A, Graziano C, Giobbe D, et al. Spinocerebellar ataxia type 12 identified in two Italian families may mimic sporadic ataxia. Mov Disord. 2010 Jul 15; 25(9): 1269–73. DOI: 10.1002/mds.22835
- 53Choudhury S, Chatterjee S, Chatterjee K, et al. Clinical Characterization of Genetically Diagnosed Cases of Spinocerebellar Ataxia Type 12 from India. Mov Disord Clin Pract. 2017 Nov 1; 5(1): 39–46. DOI: 10.1002/mdc3.12551
- 54Bhansali S, Choudhury S, Siddique U, Basu P, Kumar H. Asymmetry of Tremor in Spinocerebellar Ataxia 12- Exception or Rule? Mov Disord Clin Pract. 2021 May 25; 8(5): 809–811. DOI: 10.1002/mdc3.13237
- 55Yao T, Qiao H, Sun J, et al. Clinical and Preclinical Neuroimaging Changes in Spinocerebellar Ataxia Type 12: A Study of Three Chinese Pedigrees. Eur Neurol. 2022; 85(6): 467–477. DOI: 10.1159/000525272
- 56Rossi J, Cavallieri F, Giovannini G, et al. Spasmodic dysphonia as a presenting symptom of spinocerebellar ataxia type 12. Neurogenetics. 2019 Aug; 20(3): 161–164. DOI: 10.1007/s10048-019-00580-7
- 57Holla VV, Prasad S, Kamble N, Pal PK. Spinocerebellar Ataxia Type 12 with an Atypical Ethnicity: A Report of 2 Families. Ann Indian Acad Neurol. 2021 Jul–Aug; 24(4): 614–616. DOI: 10.4103/aian.AIAN_930_20
- 58Ganos C, Saifee TA, Kassavetis P, et al. Dystonic Tremor and Spasmodic Dysphonia in Spinocerebellar Ataxia Type 12. Mov Disord Clin Pract. 2014 Apr 10; 1(1): 79–81. DOI: 10.1002/mdc3.12006
- 59Kalia LV, Rockman-Greenberg C, Borys A, Lang AE. Tremor in Spinocerebellar Ataxia Type 12. Mov Disord Clin Pract. 2014 Apr 10; 1(1): 76–78. DOI: 10.1002/mdc3.12015
- 60Bhattad S, Rawat CS, Pandey S. Monochorea of the Upper Limb in a Patient with Spinocerebellar Ataxia Type 12. Mov Disord Clin Pract. 2021 Sep 3; 8(Suppl 1): S51–S52. DOI: 10.1002/mdc3.13288
- 61Lang AE, Bhattad S, Rawat CS, Pandey S, Sethi KD. Commentary: Monochorea of the Upper Limb in a Patient with Spinocerebellar Ataxia Type 12. Mov Disord Clin Pract. 2021 Sep 3; 8(Suppl 1): S53–S54. DOI: 10.1002/mdc3.13290
- 62Vlak MH, Sinke RJ, Rabelink GM, Kremer BP, van de Warrenburg BP. Novel PRKCG/SCA14 mutation in a Dutch spinocerebellar ataxia family: expanding the phenotype. Mov Disord. 2006 Jul; 21(7): 1025–8. DOI: 10.1002/mds.20851
- 63Foncke EM, Beukers RJ, Tijssen CC, Koelman JH, Tijssen MA. Myoclonus-dystonia and spinocerebellar ataxia type 14 presenting with similar phenotypes: trunk tremor, myoclonus, and dystonia. Parkinsonism Relat Disord. 2010 May; 16(4): 288–9. DOI: 10.1016/j.parkreldis.2009.10.008
- 64Koht J, Stevanin G, Durr A, Mundwiller E, Brice A, Tallaksen CM. SCA14 in Norway, two families with autosomal dominant cerebellar ataxia and a novel mutation in the PRKCG gene. Acta Neurol Scand. 2012 Feb; 125(2): 116–22. DOI: 10.1111/j.1600-0404.2011.01504.x
- 65Riso V, Rossi S, Perna A, Nicoletti T, Bosco L, Zanni G, Silvestri G. NGS-based detection of a novel mutation in PRKCG (SCA14) in sporadic adult-onset ataxia plus dystonic tremor. Neurol Sci. 2020 Oct; 41(10): 2989–2991. DOI: 10.1007/s10072-020-04443-0
- 66Klebe S, Durr A, Rentschler A, et al. New mutations in protein kinase Cgamma associated with spinocerebellar ataxia type 14. Ann Neurol. 2005 Nov; 58(5): 720–9. DOI: 10.1002/ana.20628
- 67Chelban V, Wiethoff S, Fabian-Jessing BK, et al. Genotype-phenotype correlations, dystonia and disease progression in spinocerebellar ataxia type 14. Mov Disord. 2018 Jul; 33(7): 1119–1129. DOI: 10.1002/mds.27334
- 68Rossi M, Hamed M, Rodríguez-Antigüedad J, et al. Genotype-Phenotype Correlations for ATX-TBP (SCA17): MDSGene Systematic Review. Mov Disord. 2023 Mar; 38(3): 368–377. DOI: 10.1002/mds.29278
- 69Nakamura K, Jeong SY, Uchihara T, et al. SCA17, a novel autosomal dominant cerebellar ataxia caused by an expanded polyglutamine in TATA-binding protein. Hum Mol Genet. 2001 Jul 1; 10(14): 1441–8. DOI: 10.1093/hmg/10.14.1441
- 70Nielsen TT, Mardosiene S, Løkkegaard A, et al. Severe and rapidly progressing cognitive phenotype in a SCA17-family with only marginally expanded CAG/CAA repeats in the TATA-box binding protein gene: a case report. BMC Neurol. 2012 Aug 13; 12: 73. DOI: 10.1186/1471-2377-12-73
- 71Oyama G, Thompson A, Foote KD, et al. Deep brain stimulation for tremor associated with underlying ataxia syndromes: a case series and discussion of issues. Tremor Other Hyperkinet Mov (N Y). 2014 Jul 9; 4: 228. DOI: 10.5334/tohm.180
- 72Echeveste B, Covarrubias E, Cabello JP, Luquin MR. Isolated palatal tremor as unique clinical manifestation of SCA 18 due to a new mutation of IFRD1. Parkinsonism Relat Disord. 2017 Sep; 42: 100–101. DOI: 10.1016/j.parkreldis.2017.05.026
- 73Schelhaas HJ, Ippel PF, Hageman G, Sinke RJ, van der Laan EN, Beemer FA. Clinical and genetic analysis of a four-generation family with a distinct autosomal dominant cerebellar ataxia. J Neurol. 2001 Feb; 248(2): 113–20. DOI: 10.1007/s004150170245
- 74Palombo F, La Morgia C, Fiorini C, et al. A Second Case With the V374 A KCND3 Pathogenic Variant in an Italian Patient With Early-Onset Spinocerebellar Ataxia. Neurol Genet. 2022 Aug 8; 8(5):
e200004 . DOI: 10.1212/NXG.0000000000200004 - 75Storey E, Gardner RJ. Spinocerebellar ataxia type 20. Handb Clin Neurol. 2012; 103: 567–73. DOI: 10.1016/B978-0-444-51892-7.00038-3
- 76Knight MA, Gardner RJ, Bahlo M, et al. Dominantly inherited ataxia and dysphonia with dentate calcification: spinocerebellar ataxia type 20. Brain. 2004 May; 127(Pt 5): 1172–81. DOI: 10.1093/brain/awh139
- 77Vuillaume I, Devos D, Schraen-Maschke S, et al. A new locus for spinocerebellar ataxia (SCA21) maps to chromosome 7p21.3-p15.1. Ann Neurol. 2002 Nov; 52(5): 666–70. DOI: 10.1002/ana.10344
- 78Riso V, Galatolo D, Barghigiani M, et al. A next generation sequencing-based analysis of a large cohort of ataxic patients refines the clinical spectrum associated with spinocerebellar ataxia 21. Eur J Neurol. 2021 Aug; 28(8): 2784–2788. DOI: 10.1111/ene.14868
- 79Traschütz A, van Gaalen J, Oosterloo M, et al. The movement disorder spectrum of SCA21 (ATX-TMEM240): 3 novel families and systematic review of the literature. Parkinsonism Relat Disord. 2019 May; 62: 215–220. DOI: 10.1016/j.parkreldis.2018.11.027
- 80Zeng S, Zeng J, He M, et al. Spinocerebellar ataxia type 21 exists in the Chinese Han population. Sci Rep. 2016 Jan 27; 6: 19897. DOI: 10.1038/srep19897
- 81Camargo CHF, Piva-Silva AKC, Munhoz RP, Raskin S, Teive HAG. Spinocerebellar ataxia type 21 (TMEM240) with tremor and dystonia. Eur J Neurol. 2021 Aug; 28(8): e63–e64. DOI: 10.1111/ene.14944
- 82van Swieten JC, Brusse E, de Graaf BM, et al. A mutation in the fibroblast growth factor 14 gene is associated with autosomal dominant cerebellar ataxia [corrected]. Am J Hum Genet. 2003 Jan; 72(1): 191–9. DOI: 10.1086/345488
- 83Brusse E, de Koning I, Maat-Kievit A, Oostra BA, Heutink P, van Swieten JC. Spinocerebellar ataxia associated with a mutation in the fibroblast growth factor 14 gene (SCA27): A new phenotype. Mov Disord. 2006 Mar; 21(3): 396–401. DOI: 10.1002/mds.20708
- 84Coebergh JA, Fransen van de Putte DE, Snoeck IN, Ruivenkamp C, van Haeringen A, Smit LM. A new variable phenotype in spinocerebellar ataxia 27 (SCA 27) caused by a deletion in the FGF14 gene. Eur J Paediatr Neurol. 2014 May; 18(3): 413–5. DOI: 10.1016/j.ejpn.2013.10.006
- 85Groth CL, Berman BD. Spinocerebellar Ataxia 27: A Review and Characterization of an Evolving Phenotype. Tremor Other Hyperkinet Mov (N Y). 2018 Jan 30; 8: 534. DOI: 10.5334/tohm.436
- 86Paucar M, Lundin J, Alshammari T, et al. Broader phenotypic traits and widespread brain hypometabolism in spinocerebellar ataxia 27. J Intern Med. 2020 Jul; 288(1): 103–115. DOI: 10.1111/joim.13052
- 87Piarroux J, Riant F, Humbertclaude V, et al. FGF14-related episodic ataxia: delineating the phenotype of Episodic Ataxia type 9. Ann Clin Transl Neurol. 2020 Apr; 7(4): 565–572. DOI: 10.1002/acn3.51005
- 88Pellerin D, Danzi MC, Wilke C, et al. Deep Intronic FGF14 GAA Repeat Expansion in Late-Onset Cerebellar Ataxia. N Engl J Med. 2023 Jan 12; 388(2): 128–141. DOI: 10.1056/NEJMoa2207406
- 89Rafehi H, Read J, Szmulewicz DJ, et al. An intronic GAA repeat expansion in FGF14 causes the autosomal-dominant adult-onset ataxia SCA27B/ATX-FGF14. Am J Hum Genet. 2023 Jun 1; 110(6): 1018. DOI: 10.1016/j.ajhg.2023.05.005
- 90Online Mendelian Inheritance in Man, OMIM®. Johns Hopkins University, Baltimore, MD. MIM Number: 193003: 10/11/2022: World Wide Web URL:
https://omim.org/ . - 91Online Mendelian Inheritance in Man, OMIM®. Johns Hopkins University, Baltimore, MD. MIM Number: 620174: 01/18/2023: World Wide Web URL:
https://omim.org/ . - 92Zambonin JL, Bellomo A, Ben-Pazi H, et al; Care4Rare Canada Consortium; Dudding-Byth T, Boycott KM. Spinocerebellar ataxia type 29 due to mutations in ITPR1: a case series and review of this emerging congenital ataxia. Orphanet J Rare Dis. 2017 Jun 28; 12(1): 121. DOI: 10.1186/s13023-017-0672-7
- 93Wang L, Hao Y, Yu P, et al. Identification of a Splicing Mutation in ITPR1 via WES in a Chinese Early-Onset Spinocerebellar Ataxia Family. Cerebellum. 2018 Jun; 17(3): 294–299. DOI: 10.1007/s12311-017-0896-z
- 94Ngo KJ, Poke G, Neas K, Fogel BL. Spinocerebellar Ataxia type 29 in a family of Māori descent. Cerebellum Ataxias. 2019 Oct 12; 6: 14. DOI: 10.1186/s40673-019-0108-3
- 95Guo YC, Lin JJ, Liao YC, Tsai PC, Lee YC, Soong BW. Spinocerebellar ataxia 35: novel mutations in TGM6 with clinical and genetic characterization. Neurology. 2014 Oct 21; 83(17): 1554–61. DOI: 10.1212/WNL.0000000000000909
- 96Wang JL, Yang X, Xia K, et al. TGM6 identified as a novel causative gene of spinocerebellar ataxias using exome sequencing. Brain. 2010 Dec; 133(Pt 12): 3510–8. DOI: 10.1093/brain/awq323
- 97Fasano A, Hodaie M, Munhoz RP, Rohani M. SCA 35 presenting as isolated treatment-resistant dystonic hand tremor. Parkinsonism Relat Disord. 2017 Apr; 37: 118–119. DOI: 10.1016/j.parkreldis.2017.01.014
- 98Obayashi M, Stevanin G, Synofzik M, et al. Spinocerebellar ataxia type 36 exists in diverse populations and can be caused by a short hexanucleotide GGCCTG repeat expansion. J Neurol Neurosurg Psychiatry. 2015 Sep; 86(9): 986–95. DOI: 10.1136/jnnp-2014-309153
- 99Emamikhah M, Aghavali S, Moghadas F, et al. Spinocerebellar Ataxia 40: Another Etiology Underlying Essential Tremor Syndrome. Mov Disord Clin Pract. 2021 May 25; 8(6): 944–946. DOI: 10.1002/mdc3.13251
- 100Tsoi H, Yu AC, Chen ZS, et al. A novel missense mutation in CCDC88C activates the JNK pathway and causes a dominant form of spinocerebellar ataxia. J Med Genet. 2014 Sep; 51(9): 590–5. DOI: 10.1136/jmedgenet-2014-102333
- 101Boros FA, Szpisjak L, Bozó R, et al. Spinocerebellar Ataxia in a Hungarian Female Patient with a Novel Variant of Unknown Significance in the CCDC88C Gene. Int J Mol Sci. 2023 Jan 30; 24(3): 2617. DOI: 10.3390/ijms24032617
- 102Han F, Su D, Qu C. Spinocerebellar ataxia type 40: A case report and literature review. Transl Neurosci. 2021 Oct 18; 12(1): 379–384. DOI: 10.1515/tnsci-2020-0190
- 103Leńska-Mieciek M, Charzewska A, Królicki L, et al. Familial ataxia, tremor, and dementia in a polish family with a novel mutation in the CCDC88C gene. Mov Disord. 2019 Jan; 34(1): 142–144. DOI: 10.1002/mds.27536
- 104Hara N, Nezu T, Kobatake K, Morino H, Kawakami H, Maruyama H. Treatment of intractable resting tremor of spinocerebellar ataxia 42 with zonisamide. J Neurol Sci. 2019 Jan 15; 396: 119–120. DOI: 10.1016/j.jns.2018.11.013
- 105Ngo K, Aker M, Petty LE, et al. Expanding the global prevalence of spinocerebellar ataxia type 42. Neurol Genet. 2018 Apr 5; 4(3):
e232 . DOI: 10.1212/NXG.0000000000000232 - 106Coutelier M, Blesneac I, Monteil A, et al. A Recurrent Mutation in CACNA1G Alters Cav3.1 T-Type Calcium-Channel Conduction and Causes Autosomal-Dominant Cerebellar Ataxia. Am J Hum Genet. 2015 Nov 5; 97(5): 726–37. DOI: 10.1016/j.ajhg.2015.09.007
- 107Morino H, Matsuda Y, Muguruma K, et al. A mutation in the low voltage-gated calcium channel CACNA1G alters the physiological properties of the channel, causing spinocerebellar ataxia. Mol Brain. 2015 Dec 29; 8: 89. DOI: 10.1186/s13041-015-0180-4
- 108De Michele G, Lieto M, Galatolo D, et al. Spinocerebellar ataxia 48 presenting with ataxia associated with cognitive, psychiatric, and extrapyramidal features: A report of two Italian families. Parkinsonism Relat Disord. 2019 Aug; 65: 91–96. DOI: 10.1016/j.parkreldis.2019.05.001
- 109Lieto M, Riso V, Galatolo D, et al. The complex phenotype of spinocerebellar ataxia type 48 in eight unrelated Italian families. Eur J Neurol. 2020 Mar; 27(3): 498–505. DOI: 10.1111/ene.14094
- 110Online Mendelian Inheritance in Man, OMIM®. Johns Hopkins University, Baltimore, MD. MIM Number: 620158: 03/13/2023: World Wide Web URL:
https://omim.org/ . - 111Coutelier M, Jacoupy M, Janer A, et al. NPTX1 mutations trigger endoplasmic reticulum stress and cause autosomal dominant cerebellar ataxia. Brain. 2022 May 24; 145(4): 1519–1534. DOI: 10.1093/brain/awab407
- 112Velázquez-Pérez L, Cerecedo-Zapata CM, Hernández-Hernández O, et al. A comprehensive clinical and genetic study of a large Mexican population with spinocerebellar ataxia type 7. Neurogenetics. 2015 Jan; 16(1): 11–21. DOI: 10.1007/s10048-014-0424-y
- 113Salas-Vargas J, Mancera-Gervacio J, Velázquez-Pérez L, et al. Spinocerebellar ataxia type 7: a neurodegenerative disorder with peripheral neuropathy. Eur Neurol. 2015; 73(3–4): 173–8. DOI: 10.1159/000370239
- 114David G, Dürr A, Stevanin G, et al. Molecular and clinical correlations in autosomal dominant cerebellar ataxia with progressive macular dystrophy (SCA7). Hum Mol Genet. 1998 Feb; 7(2): 165–70. DOI: 10.1093/hmg/7.2.165
- 115Gu W, Wang Y, Liu X, Zhou B, Zhou Y, Wang G. Molecular and clinical study of spinocerebellar ataxia type 7 in Chinese kindreds. Arch Neurol. 2000 Oct; 57(10): 1513–8. DOI: 10.1001/archneur.57.10.1513
- 116Modi G, Modi M, Martinus I, Rodda J, Saffer D. The clinical and genetic characteristics of spinocerebellar ataxia type 7 (SCA 7) in three Black South African families. Acta Neurol Scand. 2000 Mar; 101(3): 177–82. DOI: 10.1034/j.1600-0404.2000.101003177.x
- 117Bürk K, Zühlke C, König IR, et al. Spinocerebellar ataxia type 5: clinical and molecular genetic features of a German kindred. Neurology. 2004 Jan 27; 62(2): 327–9. DOI: 10.1212/01.wnl.0000103293.63340.c1
- 118Mizuno T, Kashimada A, Nomura T, et al. Infantile-onset spinocerebellar ataxia type 5 associated with a novel SPTBN2 mutation: A case report. Brain Dev. 2019 Aug; 41(7): 630–633. DOI: 10.1016/j.braindev.2019.03.002
- 119Jacob FD, Ho ES, Martinez-Ojeda M, Darras BT, Khwaja OS. Case of infantile onset spinocerebellar ataxia type 5. J Child Neurol. 2013 Oct; 28(10): 1292–5. DOI: 10.1177/0883073812454331
- 120Watanabe H, Tanaka F, Matsumoto M, et al. Frequency analysis of autosomal dominant cerebellar ataxias in Japanese patients and clinical characterization of spinocerebellar ataxia type 6. Clin Genet. 1998 Jan; 53(1): 13–9. DOI: 10.1034/j.1399-0004.1998.531530104.x
- 121Nishida T, Nakajima M. A refractory head tremor appearing after volatile anesthesia combined with epidural anesthesia in a patient with spinocerebellar ataxia type 6. JA Clin Rep. 2018 Jan 30; 4(1): 13. DOI: 10.1186/s40981-018-0150-9
- 122Hara K, Fukushima T, Suzuki T, et al. Japanese SCA families with an unusual phenotype linked to a locus overlapping with SCA15 locus. Neurology. 2004 Feb 24; 62(4): 648–51. DOI: 10.1212/01.wnl.0000110190.08412.25
- 123Marelli C, van de Leemput J, Johnson JO, et al. SCA15 due to large ITPR1 deletions in a cohort of 333 white families with dominant ataxia. Arch Neurol. 2011 May; 68(5): 637–43. DOI: 10.1001/archneurol.2011.81
- 124Tipton PW, Guthrie K, Strongosky A, Reimer R, Wszolek ZK. Spinocerebellar ataxia 15: A phenotypic review and expansion. Neurol Neurochir Pol. 2017 Jan–Feb; 51(1): 86–91. DOI: 10.1016/j.pjnns.2016.10.006
- 125Miyoshi Y, Yamada T, Tanimura M, et al. A novel autosomal dominant spinocerebellar ataxia (SCA16) linked to chromosome 8q22.1-24.1. Neurology. 2001 Jul 10; 57(1): 96–100. DOI: 10.1212/wnl.57.1.96
- 126Storey E, Gardner RJ. Spinocerebellar ataxia type 15. Handb Clin Neurol. 2012; 103: 561–5. DOI: 10.1016/B978-0-444-51892-7.00037-1
- 127Sasaki M, Ohba C, Iai M, et al. Sporadic infantile-onset spinocerebellar ataxia caused by missense mutations of the inositol 1,4,5-triphosphate receptor type 1 gene. J Neurol. 2015 May; 262(5): 1278–84. DOI: 10.1007/s00415-015-7705-8
- 128Wu F, Wang X, Li X, Teng H, Tian T, Bai J. Spinocerebellar ataxia type 23 (SCA23): a review. J Neurol. 2021 Dec; 268(12): 4630–4645. DOI: 10.1007/s00415-020-10297-5
- 129Saigoh K, Mitsui J, Hirano M, et al. The first Japanese familial case of spinocerebellar ataxia 23 with a novel mutation in the PDYN gene. Parkinsonism Relat Disord. 2015 Mar; 21(3): 332–4. DOI: 10.1016/j.parkreldis.2014.12.028
- 130Bakalkin G, Watanabe H, Jezierska J, et al. Prodynorphin mutations cause the neurodegenerative disorder spinocerebellar ataxia type 23. Am J Hum Genet. 2010 Nov 12; 87(5): 593–603. DOI: 10.1016/j.ajhg.2010.10.001
- 131Satoh S, Kondo Y, Ohara S, Yamaguchi T, Nakamura K, Yoshida K. Intrafamilial phenotypic variation in spinocerebellar ataxia type 23. Cerebellum Ataxias. 2020 Jun 23; 7: 7. DOI: 10.1186/s40673-020-00117-x
- 132Saucier J, Al-Qadi M, Amor MB, Ishikawa K, Chamard-Witkowski L. Spinocerebellar ataxia type 31: A clinical and radiological literature review. J Neurol Sci. 2023 Jan 15; 444: 120527. DOI: 10.1016/j.jns.2022.120527
- 133Norioka R, Sugaya K, Murayama A, et al. Midbrain atrophy related to parkinsonism in a non-coding repeat expansion disorder: five cases of spinocerebellar ataxia type 31 with nigrostriatal dopaminergic dysfunction. Cerebellum Ataxias. 2021 Mar 30; 8(1): 11. DOI: 10.1186/s40673-021-00134-4
- 134Corral-Juan M, Serrano-Munuera C, Rábano A, et al. Clinical, genetic and neuropathological characterization of spinocerebellar ataxia type 37. Brain. 2018 Jul 1; 141(7): 1981–1997. DOI: 10.1093/brain/awy137
- 135Seidel K, Siswanto S, Brunt ER, den Dunnen W, Korf HW, Rüb U. Brain pathology of spinocerebellar ataxias. Acta Neuropathol. 2012; 124: 1–21. DOI: 10.1007/s00401-012-1000-x
- 136Meira AT, Arruda WO, Ono SE, et al. Neuroradiological Findings in the Spinocerebellar Ataxias. Tremor Other Hyperkinet Mov (N Y). 2019 Sep 26; 9. DOI: 10.5334/tohm.516
- 137Hashimoto T, Muralidharan A, Yoshida K, et al. Neuronal activity and outcomes from thalamic surgery for spinocerebellar ataxia. Ann Clin Transl Neurol. 2017 Dec 10; 5(1): 52–63. DOI: 10.1002/acn3.508
- 138Purrer V, Upadhyay N, Pieper CC, et al. Magnetic Resonance Imaging-Guided Focused Ultrasound Thalamotomy in Spinocerebellar Ataxia Type 12. Mov Disord. 2022 Apr; 37(4): 872–873. DOI: 10.1002/mds.28918
- 139Cury RG, França C, Duarte KP, et al. Safety and Outcomes of Dentate Nucleus Deep Brain Stimulation for Cerebellar Ataxia. Cerebellum. 2022 Oct; 21(5): 861–865. DOI: 10.1007/s12311-021-01326-8
- 140Mascalchi M, Vella A. Neuroimaging Applications in Chronic Ataxias. Int Rev Neurobiol. 2018; 143: 109–162. DOI: 10.1016/bs.irn.2018.09.011
- 141Hallett M. Parkinson’s disease tremor: pathophysiology. Parkinsonism Relat Disord. 2012 Jan; 18(Suppl 1): S85–6. DOI: 10.1016/S1353-8020(11)70027-X
- 142Latorre A, Del Gamba C, Menozzi E, Balint B, Brugger F, Bhatia KP. Abnormal DaTSCAN and Atypical Parkinsonism in SCA12. Mov Disord Clin Pract. 2019 Mar 28; 6(5): 400–402. DOI: 10.1002/mdc3.12751
- 143DeSimone JC, Archer DB, Vaillancourt DE, Wagle Shukla A. Network-level connectivity is a critical feature distinguishing dystonic tremor and essential tremor. Brain. 2019 Jun 1; 142(6): 1644–1659. DOI: 10.1093/brain/awz085
- 144Nieuwhof F, Toni I, Dirkx MF, et al. Cerebello-thalamic activity drives an abnormal motor network into dystonic tremor. Neuroimage Clin. 2022; 33: 102919. DOI: 10.1016/j.nicl.2021.102919
- 145Panyakaew P, Cho HJ, Lee SW, Wu T, Hallett M. The Pathophysiology of Dystonic Tremors and Comparison With Essential Tremor. J Neurosci. 2020 Nov 25; 40(48): 9317–9326. DOI: 10.1523/JNEUROSCI.1181-20.2020
- 146Caligiore D, Pezzulo G, Baldassarre G, et al. Consensus Paper: Towards a Systems-Level View of Cerebellar Function: the Interplay Between Cerebellum, Basal Ganglia, and Cortex. Cerebellum. 2017 Feb; 16(1): 203–229. DOI: 10.1007/s12311-016-0763-3
- 147O’Hearn EE, Hwang HS, Holmes SE, et al. Neuropathology and Cellular Pathogenesis of Spinocerebellar Ataxia Type 12. Mov Disord. 2015 Nov; 30(13): 1813–1824. DOI: 10.1002/mds.26348
- 148Kumar D, Srivastava AK, Faruq M, Gundluru VR. Spinocerebellar ataxia type 12: An update. Annals of Movement Disorders. 2019; 2(2): 48–57. DOI: 10.4103/AOMD.AOMD_5_19
- 149O’Hearn E, Holmes SE, Margolis RL. Spinocerebellar ataxia type 12. Handb Clin Neurol. 2012; 103: 535–47. DOI: 10.1016/B978-0-444-51892-7.00034-6
- 150Lu CS, Wu Chou YH, Kuo PC, Chang HC, Weng YH. The parkinsonian phenotype of spinocerebellar ataxia type 2. Arch Neurol. 2004 Jan; 61(1): 35–8. DOI: 10.1001/archneur.61.1.35
- 151Simon-Sanchez J, Hanson M, Singleton A, et al. Analysis of SCA-2 and SCA-3 repeats in Parkinsonism: evidence of SCA-2 expansion in a family with autosomal dominant Parkinson’s disease. Neurosci Lett. 2005 Jul 1–8; 382(1–2): 191–4. DOI: 10.1016/j.neulet.2005.03.015
- 152Socal MP, Emmel VE, Rieder CR, Hilbig A, Saraiva-Pereira ML, Jardim LB. Intrafamilial variability of Parkinson phenotype in SCAs: novel cases due to SCA2 and SCA3 expansions. Parkinsonism Relat Disord. 2009 Jun; 15(5): 374–8. DOI: 10.1016/j.parkreldis.2008.09.005
- 153Boesch SM, Donnemiller E, Müller J, et al. Abnormalities of dopaminergic neurotransmission in SCA2: a combined 123I-betaCIT and 123I-IBZM SPECT study. Mov Disord. 2004 Nov; 19(11): 1320–5. DOI: 10.1002/mds.20159
- 154Horimoto Y, Hayashi E, Ito Y, et al. Dopaminergic function in spinocerebellar ataxia type 6 patients with and without parkinsonism. J Neurol. 2020 Sep; 267(9): 2692–2696. DOI: 10.1007/s00415-020-09908-y
- 155Hara N, Morino H, Matsuda Y, et al. Zonisamide can ameliorate the voltage-dependence alteration of the T-type calcium channel CaV3.1 caused by a mutation responsible for spinocerebellar ataxia. Mol Brain. 2020 Nov 26; 13(1): 163. DOI: 10.1186/s13041-020-00700-7
- 156Matthews LG, Puryear CB, Correia SS, et al. T-type calcium channels as therapeutic targets in essential tremor and Parkinson’s disease. Ann Clin Transl Neurol. 2023 Apr; 10(4): 462–483. DOI: 10.1002/acn3.51735
- 157Freund HJ, Barnikol UB, Nolte D, et al. Subthalamic-thalamic DBS in a case with spinocerebellar ataxia type 2 and severe tremor-A unusual clinical benefit. Mov Disord. 2007 Apr 15; 22(5): 732–5. DOI: 10.1002/mds.21338
- 158Kuo MC, Tai CH, Tseng SH, Wu RM. Long-term efficacy of bilateral subthalamic deep brain stimulation in the parkinsonism of SCA 3: A rare case report. Eur J Neurol. 2022 Aug; 29(8): 2544–2547. DOI: 10.1111/ene.15339
- 159Chiu SY, Nozile-Firth K, Klassen BT, et al. Ataxia and tolerance after thalamic deep brain stimulation for essential tremor. Parkinsonism Relat Disord. 2020 Nov; 80: 47–53. DOI: 10.1016/j.parkreldis.2020.09.009
- 160Reich MM, Brumberg J, Pozzi NG, et al. Progressive gait ataxia following deep brain stimulation for essential tremor: adverse effect or lack of efficacy? Brain. 2016 Nov 1; 139(11): 2948–2956. DOI: 10.1093/brain/aww223
- 161Elias WJ, Lipsman N, Ondo WG, et al. A Randomized Trial of Focused Ultrasound Thalamotomy for Essential Tremor. N Engl J Med. 2016 Aug 25; 375(8): 730–9. DOI: 10.1056/NEJMoa1600159
- 162Bond AE, Shah BB, Huss DS, et al. Safety and Efficacy of Focused Ultrasound Thalamotomy for Patients With Medication-Refractory, Tremor-Dominant Parkinson Disease: A Randomized Clinical Trial. JAMA Neurol. 2017 Dec 1; 74(12): 1412–1418. DOI: 10.1001/jamaneurol.2017.3098
